InMed Pharmaceuticals Inc. (INM) income statement
INMNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as MTRI
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$1.37+0.05 (+3.44%)
Close on Oct 19, 2026Market cap $83.97MP/E –Yield –
InMed Pharmaceuticals Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -173.1%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?